ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

BiFinance Lists EVOCARE-USDT and Launches Trading Competition with Exclusive Rewards

BiFinance, a leading Web3 digital asset trading platform, has officially announced the listing of EVOCARE (EVOCARE) and the launch of a dedicated trading competition, offering users multiple participation opportunities and enhanced engagement.

EVOCARE Officially Listed on BiFinance

According to the official announcement, BiFinance has listed the EVOCARE USDT trading pair, with deposit and trading services opened on March 12, 2026.

EVOCARE represents an innovative Web3 healthcare initiative focused on building a digital therapy ecosystem. As The World Therapy Store, EvoCare aims to connect patients, therapists, and healthcare creators through a scalable and compliant infrastructure, integrating real-world medical services with blockchain technology and bringing real-world utility into the Web3 space.

The platform combines regulated healthcare services with Web3 utility infrastructure, creating a scalable global ecosystem for therapy, rehabilitation, and digital health services. EvoCare is designed to enable German-quality therapeutic care to be delivered anywhere in the world through a clinically supervised digital healthcare platform.

Official Website:

https://evocare.healthcare

The EVOCARE token serves as the core of the ecosystem, supporting:

Digital therapy service payments

Creator support mechanisms

Access to regulated healthcare solutions

By linking real healthcare demand with tokenized utility, EVOCARE creates a sustainable and value-driven ecosystem backed by real-world applications.

Trading Competition Now Live with Trading Competition Details

To celebrate the listing, BiFinance has launched the EVOCARE Trading Competition, allowing users to trade EVOCARE USDT and compete for benefits.

Participants can:

Trade EVOCARE USDT to climb leaderboard rankings

Receive benefits based on trading performance

Unlock additional advantages such as trading additional benefits

The competition is designed to encourage active participation while benefiting both new and experienced traders.

Expanding the RWA and Utility-Driven Ecosystem

The listing of EVOCARE reflects BiFinance’s continued commitment to supporting projects with real-world utility and strong growth potential. By bridging traditional sectors such as healthcare with blockchain infrastructure, BiFinance further strengthens its “virtual + real” ecosystem strategy.

Through ongoing listings, trading campaigns, and ecosystem collaboration, BiFinance aims to provide users with:

High-quality asset access

Enhanced trading opportunities

A more diversified and utility-driven Web3 experience

About BiFinance

BiFinance is a Web3 digital asset trading platform focused on the integration of Real-World Assets (RWA) and blockchain technology. The platform is committed to building a secure, compliant, and scalable financial ecosystem, connecting traditional finance with the decentralized world.

With a growing global presence and continuous innovation in both product and ecosystem design, BiFinance is accelerating the evolution of digital finance through its “Bi+Finance” model.

Media Contact

Organization: BiFinance

Contact Person: Ben

Website: https://www.bifinance.com

Email:
listing@BiFinance.com

Country:Canada

Release id:42777

View source version on King Newswire:
BiFinance Lists EVOCARE-USDT and Launches Trading Competition with Exclusive Rewards

 

file

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.37
-3.39 (-1.62%)
AAPL  247.99
-0.97 (-0.39%)
AMD  201.33
-3.94 (-1.92%)
BAC  47.16
+0.15 (0.32%)
GOOG  298.79
-6.94 (-2.27%)
META  593.66
-13.04 (-2.15%)
MSFT  381.87
-7.15 (-1.84%)
NVDA  172.70
-5.86 (-3.28%)
ORCL  149.68
-5.84 (-3.76%)
TSLA  367.96
-12.34 (-3.24%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.